Phase II Trial of Nab-paclitaxel (Abraxane) in Patients With Relapsed or Refractory Multiple Myeloma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Dec 2016
At a glance
- Drugs Paclitaxel (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 20 Dec 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.
- 03 Jun 2016 Planned primary completion date changed from 1 Feb 2015 to 1 Sep 2016.
- 03 Jun 2016 Status changed from completed to active, no longer recruiting.